Axel Dignaß

Active 1991–2025

Also published as
Axel Dignass
130
Papers
29,739
Citations
77
h-index
122
i10-index

Citations

Citations per year for Axel Dignaß1980: 1 citations1994: 6 citations1995: 12 citations1996: 12 citations1997: 33 citations1998: 27 citations1999: 50 citations2000: 35 citations2001: 35 citations2002: 33 citations2003: 35 citations2004: 34 citations2005: 37 citations2006: 61 citations2007: 73 citations2008: 111 citations2009: 110 citations2010: 120 citations2011: 140 citations2012: 134 citations2013: 198 citations2014: 197 citations2015: 195 citations2016: 221 citations2017: 258 citations2018: 273 citations2019: 1,028 citations2020: 1,096 citations2021: 929 citations2022: 831 citations2023: 689 citations2024: 1,177 citations2025: 521 citations2026: 8 citations1981–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,845 citing papers, 15.4% of this breakdownUnited Kingdom: 931 citing papers, 7.7% of this breakdownItaly: 924 citing papers, 7.7% of this breakdownChina: 841 citing papers, 7% of this breakdownGermany: 699 citing papers, 5.8% of this breakdownCanada: 635 citing papers, 5.3% of this breakdownFrance: 605 citing papers, 5% of this breakdownSpain: 495 citing papers, 4.1% of this breakdownNetherlands: 481 citing papers, 4% of this breakdownBelgium: 359 citing papers, 3% of this breakdownJapan: 338 citing papers, 2.8% of this breakdownAustralia: 284 citing papers, 2.4% of this breakdown
0%15.4%Other 29.8%

Fields

  • Biochemistry, Genetics and Molecular Biology54.3%
  • Medicine32.5%
  • Immunology and Microbiology5.8%
  • Nursing2.7%
  • Agricultural and Biological Sciences1.2%
  • Neuroscience1%
  • Other2.5%

Topics

  • Inflammatory Bowel Disease19.4%
  • Microscopic Colitis6.6%
  • Gut microbiota and health3.5%
  • Autoimmune and Inflammatory Disorders2.8%
  • Rheumatoid Arthritis Research and Therapies2.2%
  • Iron Metabolism and Disorders1.9%
  • Other63.6%

Coauthors

All papers

Open in search
  1. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    Authors: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 2,666

  2. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 2,071

  3. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2016 cited by 1,064

  4. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

    Authors: , , , , , , , , , , , , - Journal of Crohn s and Colitis 2017 cited by 1,164

  5. Ulcerative Colitis—Diagnostic and Therapeutic Algorithms

    Authors: , , , - Deutsches Ärzteblatt international 2020 cited by 260

  6. European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

    Authors: , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2014 cited by 611

  7. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management

    Authors: , , , , , , , , , , , , , , - American Journal of Hematology 2017 cited by 506

  8. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier P. Gisbert, Rosana Palasí, Javier Pérez Gisbert, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Ricardo Rada, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, Xavier González-Argenté, C. Martínez Pastor, Héctor Guadalajara, C. Martínez Pastor, Héctor Guadalajara - Gastroenterology 2017 cited by 485

  9. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 760

  10. An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2018 cited by 258

  11. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abraham R. Eliakim, Harland S. Winter, Dan Turner - Journal of Crohn s and Colitis 2014 cited by 1,070

  12. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mercedes Cabello, Qian Cao, Flavio Caprioli, Rute Cerqueira, Baili Chen, Chou‐Chen Chen, Chou-Pin Chen, Cheng‐Tang Chiu, Chang Hwan Choi, Michele Cicala, Olena Datsenko, Pieter Dewint, Eugeni Domènech, Joris Dutré, George Duvall, J. C. Fernández, Rafał Filip, Ronald Fogel, Sharyle Fowler, Toshimitsu Fujii, Masayuki Fukata, Yohei Furumoto, Antonio Gasbarrini, Beata Gawdis-Wojnarska, Cyrielle Gilletta, Paolo Gionchetti, Eran Goldin, Oleksandr Golovchenko, Maciej Gonciarz, Can Gönen, Gaston Gonzalez Segura, Oleksii Gridnyev, T Gyökeres, Xavier Hébuterne, Charlotte Hedin, Per M. Hellström, Ida Hilmi, Ivo Horný, Gyula Horvat, Namiko Hoshi, Luděk Hrdlička, Shunji Ishihara, Olha Ivanishyn, Byung Ik Jang, Odery Junior, Takashi Kagaya, Shuji Kanmura, Marina Karakina, Nakai Katsuhiko, Jarosław Kierkuś, Hyo Jong Kim, Tae-Oh Kim, Young‐Ho Kim, G Kiss, Jochen Klaus, D Kleczkowski, Maria Kłopocka, Taku Kobayashi, Iwona Kobielusz‐Gembala, Ja Seol Koo, Adam Kopoń, Tetiana Kravchenko, Masatoshi Kudo, Kwang An Kwon, Paula Lago, David Laharie, Ian C. Lawrance, Jarosław Leszczyszyn, Yan Li, Milan Lukáš and 64 more - Gastroenterology 2023 cited by 92

  13. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting

    Authors: , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 120

  14. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2012 cited by 1,550

  15. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer and 1 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 127

  16. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

    Authors: , , , , , , , , , , , , - Journal of Crohn s and Colitis 2012 cited by 889

  17. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonino Spinelli, A. Hillary Steinhart, Simon Travis, C. Janneke van der Woude, Bruce Yacyshyn, Takayuki Yamamoto, Matthieu Allez, Willem A. Bemelman, Amy L. Lightner, Édouard Louis, David T. Rubin, Ellen Scherl, Corey A. Siegel, Mark S. Silverberg, Séverine Vermeire, Claire E. Parker, Stefanie C. McFarlane, Leonardo Guizzetti, Michelle I. Smith, Niels Vande Casteele, Brian G. Feagan, Vipul Jairath - Gastroenterology 2022 cited by 79

  18. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions

    Authors: , , - International Journal of Chronic Diseases 2018 cited by 283

  19. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease

    Authors: , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 263

  20. Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

    Authors: , , , , , , , , - Journal of Gastroenterology 2018 cited by 171

  21. Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions

    Authors: , , , , , , , , , , - The American Journal of Gastroenterology 2023 cited by 48

  22. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2010 cited by 1,493

  23. Diagnosis and management of iron deficiency anemia in patients with IBD

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2010 cited by 303

  24. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

    Authors: , , , , , , , , , , , , , , , , , , - Drugs 2020 cited by 101